Story perspectives

UK Drug Pricing Crisis: Pharma Industry Demands Urgent Reform

8/22/2025

49 9

Summary

Story summary

UK Health Secretary Wes Streeting and pharmaceutical companies are in conflict over NHS drug pricing after failed negotiations.
The pharmaceutical industry deems the current 22.9% rebate rate unsustainable, threatening future investments and patient access.
The Association of the British Pharmaceutical Industry (ABPI) called for urgent government action to enhance sector conditions.
Industry leaders caution that without reforms, the UK may lag in research and access to medicines.

1 of 1

Story summary

UK Health Secretary Wes Streeting and pharmaceutical companies are in conflict over NHS drug pricing after failed negotiations.
The pharmaceutical industry deems the current 22.9% rebate rate unsustainable, threatening future investments and patient access.
The Association of the British Pharmaceutical Industry (ABPI) called for urgent government action to enhance sector conditions.
Industry leaders caution that without reforms, the UK may lag in research and access to medicines.